EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia

Gastrointestinal Endoscopy

Volumn 58, Issue 4, 2003, Pages 531-535

  Wamsteker, Erik Jan ^a   Gauger, Paul G ^a   Thompson, Norman W ^a   Scheiman, James M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; CANCER SCREENING; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; EVALUATION; FEMALE; FOLLOW UP; GASTRIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; ALGORITHMS; ENDOSONOGRAPHY; HUMANS; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS;

EID: 0141483264     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0016-5107(03)01965-5     Document Type: Article

References (14)

1. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA. NIH conference-multiple endocrine neoplasia: clinical and genetic topics. Ann Intern Med 1998;129:484-94.
2. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA Jr, Norton JA. Lethality of multiple endocrine neoplasia type I. World J Surg 1998;22:581-7.
3. Karges W, Schaaf L, Cralle H, Boehm BO. Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN 1). Exp Clin Endocrinol Diabetes 2000;108:334-40.
4. Schussheim DH, Skarulis MC, Agarwal SK, Simonds WF, Burns AL, Spiegel AM, Marx SJ. Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab 2001;12:173-8.
5. Granberg D, Stridsberg M, Seensalu R, Eriksson B, Lundqvist G, Oberg K, Skogseid B. Plasma chromogranin A in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1999;84:2712-7.
6. Kopp I, Bartsch D, Wild A, Schilling T, Nies C, Bergenfelz A, et al. Genetic screening in MEN-1 families. World J Surg 2001;25:610-6.
7. Bansal R, Tierney W, Carpenter S, Thompson N, Scheiman J. Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 1999;49:19-25.
8. Skogseid B, Oberg K, Eriksson B, Juhlin C, Granberg D, Akerstrom G, Rastad J. Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type 1. World J Surg 1996;20:872-7.
9. Anderson MA, Carpenter S, Thompson NW, Nostrant T, Elta GH, Scheiman JM. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000;95:2271-7.
10. Oberg K, Skogseid B. The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1. J Intern Med 1998; 243:471-6.
11. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Consensus statement: guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-71.
12. Thompson N. Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type I. Surg Oncol Clin N Am 1998;4:881-91.
13. Gauger PG, Scheiman JM, Wamsteker EJ, Richards ML, Doherty GM, Thompson NW. Role of Endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type I. Br J Surg 2003;90:748-54.
14. Delvalle J, Scheiman J. Zollinger-Ellison Syndrome. In: Yamada T, editor. Textbook of gastroenterology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 1999. p. 1445-62.